Childhood diabetes has a high mortality rate in poor countries. The life expectancy for a child with newly diagnosed type 1 diabetes in sub-Saharan Africa is typically less than one year.

The 'Changing Diabetes® in Children' programme is part of Novo Nordisk's Access to Diabetes Care Strategy, and builds on the UN-defined cornerstones in the right to health.



This site is restricted to participants of the Changing Diabetes in Children workshop.



If you would like access to the this section, please request login here.